| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts from HSG 2019
|
|
|
|
16 |
4 |
p. 1350-1390
|
artikel
|
| 2 |
Abstracts from HSG 2019
|
|
|
|
16 |
4 |
p. 1350-1390
|
artikel
|
| 3 |
Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in Mice
|
Chen, Peng
|
|
|
16 |
4 |
p. 1269-1282
|
artikel
|
| 4 |
Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in Mice
|
Chen, Peng
|
|
|
16 |
4 |
p. 1269-1282
|
artikel
|
| 5 |
At-Home Cortical Stimulation for Neuropathic Pain: a Feasibility Study with Initial Clinical Results
|
Garcia-Larrea, Luis
|
|
|
16 |
4 |
p. 1198-1209
|
artikel
|
| 6 |
At-Home Cortical Stimulation for Neuropathic Pain: a Feasibility Study with Initial Clinical Results
|
Garcia-Larrea, Luis
|
|
|
16 |
4 |
p. 1198-1209
|
artikel
|
| 7 |
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
|
Casasnovas, Carlos
|
|
|
16 |
4 |
p. 1167-1182
|
artikel
|
| 8 |
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington’s Disease: Insights from In Vitro and In Vivo Models
|
Creus-Muncunill, Jordi
|
|
|
16 |
4 |
p. 957-978
|
artikel
|
| 9 |
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models
|
Creus-Muncunill, Jordi
|
|
|
16 |
4 |
p. 957-978
|
artikel
|
| 10 |
Computer-Assisted Planning for Stereoelectroencephalography (SEEG)
|
Vakharia, Vejay N.
|
|
|
16 |
4 |
p. 1183-1197
|
artikel
|
| 11 |
Correction to: Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital
|
Ma, Dongliang
|
|
|
16 |
4 |
p. 1391
|
artikel
|
| 12 |
Correction to: Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson’s Disease Model Mice
|
Wang, Yuexiang
|
|
|
16 |
4 |
p. 1392
|
artikel
|
| 13 |
Correction to: Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson's Disease Model Mice
|
Wang, Yuexiang
|
|
|
16 |
4 |
p. 1392
|
artikel
|
| 14 |
Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin E2 and 15-Deoxy-Δ12,14-prostaglandin J2
|
Guan, Pei-Pei
|
|
|
16 |
4 |
p. 1255-1268
|
artikel
|
| 15 |
Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin E2 and 15-Deoxy-Δ12,14-prostaglandin J2
|
Guan, Pei-Pei
|
|
|
16 |
4 |
p. 1255-1268
|
artikel
|
| 16 |
DNA Damage Repair in Huntington’s Disease and Other Neurodegenerative Diseases
|
Maiuri, T.
|
|
|
16 |
4 |
p. 948-956
|
artikel
|
| 17 |
DNA Damage Repair in Huntington's Disease and Other Neurodegenerative Diseases
|
Maiuri, T.
|
|
|
16 |
4 |
p. 948-956
|
artikel
|
| 18 |
From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation
|
Da Silva, Jorge Diogo
|
|
|
16 |
4 |
p. 1009-1031
|
artikel
|
| 19 |
From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation
|
Da Silva, Jorge Diogo
|
|
|
16 |
4 |
p. 1009-1031
|
artikel
|
| 20 |
Glial Cell Line–Derived Neurotrophic Factor and Chondroitinase Promote Axonal Regeneration in a Chronic Denervation Animal Model
|
Sarhane, Karim A.
|
|
|
16 |
4 |
p. 1283-1295
|
artikel
|
| 21 |
Glial Cell Line–Derived Neurotrophic Factor and Chondroitinase Promote Axonal Regeneration in a Chronic Denervation Animal Model
|
Sarhane, Karim A.
|
|
|
16 |
4 |
p. 1283-1295
|
artikel
|
| 22 |
Induction of Neuronal PI3Kγ Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury
|
Liu, Shan
|
|
|
16 |
4 |
p. 1320-1334
|
artikel
|
| 23 |
Induction of Neuronal PI3Kγ Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury
|
Liu, Shan
|
|
|
16 |
4 |
p. 1320-1334
|
artikel
|
| 24 |
Intranasal Neuropeptide Y Blunts Lipopolysaccharide-Evoked Sickness Behavior but Not the Immune Response in Mice
|
Zenz, Geraldine
|
|
|
16 |
4 |
p. 1335-1349
|
artikel
|
| 25 |
Letter from the Editor-in-Chief: Growth of the Journal
|
Mouradian, M. Maral
|
|
|
16 |
4 |
p. 923
|
artikel
|
| 26 |
Letter from the Editor-in-Chief: Growth of the Journal
|
Mouradian, M. Maral
|
|
|
16 |
4 |
p. 923
|
artikel
|
| 27 |
Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer’s Disease Pathogenesis in a Transgenic Mouse Model
|
Baranger, Kevin
|
|
|
16 |
4 |
p. 1237-1254
|
artikel
|
| 28 |
Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model
|
Baranger, Kevin
|
|
|
16 |
4 |
p. 1237-1254
|
artikel
|
| 29 |
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
|
Naphade, Swati
|
|
|
16 |
4 |
p. 979-998
|
artikel
|
| 30 |
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
|
Naphade, Swati
|
|
|
16 |
4 |
p. 979-998
|
artikel
|
| 31 |
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31)
|
Ishikawa, Kinya
|
|
|
16 |
4 |
p. 1106-1114
|
artikel
|
| 32 |
Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease
|
Arnold, Frederick J.
|
|
|
16 |
4 |
p. 928-947
|
artikel
|
| 33 |
Molecular Mechanisms and Therapeutics for SCA17
|
Liu, Qiong
|
|
|
16 |
4 |
p. 1097-1105
|
artikel
|
| 34 |
Molecular Mechanisms and Therapeutics for SCA17
|
Liu, Qiong
|
|
|
16 |
4 |
p. 1097-1105
|
artikel
|
| 35 |
Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2
|
Egorova, Polina A.
|
|
|
16 |
4 |
p. 1050-1073
|
artikel
|
| 36 |
Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2
|
Egorova, Polina A.
|
|
|
16 |
4 |
p. 1050-1073
|
artikel
|
| 37 |
Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia
|
Gottesfeld, Joel M.
|
|
|
16 |
4 |
p. 1032-1049
|
artikel
|
| 38 |
Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia
|
Gottesfeld, Joel M.
|
|
|
16 |
4 |
p. 1032-1049
|
artikel
|
| 39 |
Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7
|
Niewiadomska-Cimicka, Anna
|
|
|
16 |
4 |
p. 1074-1096
|
artikel
|
| 40 |
Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7
|
Niewiadomska-Cimicka, Anna
|
|
|
16 |
4 |
p. 1074-1096
|
artikel
|
| 41 |
Moving Towards Therapy in SCA1: Insights from Molecular Mechanisms, Identification of Novel Targets, and Planning for Human Trials
|
Srinivasan, Sharan R.
|
|
|
16 |
4 |
p. 999-1008
|
artikel
|
| 42 |
Moving Towards Therapy in SCA1: Insights from Molecular Mechanisms, Identification of Novel Targets, and Planning for Human Trials
|
Srinivasan, Sharan R.
|
|
|
16 |
4 |
p. 999-1008
|
artikel
|
| 43 |
Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
|
Jiang, Jie
|
|
|
16 |
4 |
p. 1115-1132
|
artikel
|
| 44 |
Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
|
Jiang, Jie
|
|
|
16 |
4 |
p. 1115-1132
|
artikel
|
| 45 |
Perfusion Enhancement with Respiratory Impedance After Stroke (PERI-Stroke)
|
Favilla, Christopher G.
|
|
|
16 |
4 |
p. 1296-1303
|
artikel
|
| 46 |
Perfusion Enhancement with Respiratory Impedance After Stroke (PERI-Stroke)
|
Favilla, Christopher G.
|
|
|
16 |
4 |
p. 1296-1303
|
artikel
|
| 47 |
Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke
|
Kolosowska, Natalia
|
|
|
16 |
4 |
p. 1304-1319
|
artikel
|
| 48 |
Repeat Expansion Disorders: Mechanisms and Therapeutics
|
Ellerby, Lisa M.
|
|
|
16 |
4 |
p. 924-927
|
artikel
|
| 49 |
Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson’s Disease Models
|
Zhou, Hefeng
|
|
|
16 |
4 |
p. 1225-1236
|
artikel
|
| 50 |
Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models
|
Zhou, Hefeng
|
|
|
16 |
4 |
p. 1225-1236
|
artikel
|
| 51 |
The Medical Management of Cerebral Edema: Past, Present, and Future Therapies
|
Halstead, Michael R.
|
|
|
16 |
4 |
p. 1133-1148
|
artikel
|
| 52 |
The Medical Management of Cerebral Edema: Past, Present, and Future Therapies
|
Halstead, Michael R.
|
|
|
16 |
4 |
p. 1133-1148
|
artikel
|
| 53 |
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis
|
Bose, Poulomee
|
|
|
16 |
4 |
p. 1149-1166
|
artikel
|
| 54 |
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis
|
Bose, Poulomee
|
|
|
16 |
4 |
p. 1149-1166
|
artikel
|
| 55 |
Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson’s Disease Model Mice
|
Wang, Yuexiang
|
|
|
16 |
4 |
p. 1210-1224
|
artikel
|
| 56 |
Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson's Disease Model Mice
|
Wang, Yuexiang
|
|
|
16 |
4 |
p. 1210-1224
|
artikel
|
Tijdschrift beschrijving